![Keith McCullagh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith McCullagh
Chairman at
Xention Pharma Ltd.
Net worth: 849 933 $ as of 2026-05-30
Profile
Keith Graham McCullagh is the founder of Ligand UK Ltd. which was founded in 1986.
He held the position of Chief Executive Officer for a brief period in 1998.
Currently, he is the Chairman of Xention Pharma Ltd., Non-Executive Chairman of Metrion Biosciences Ltd., Director of Xention Ltd., and Director of Torpedo Factory Ltd. He previously held the position of President & Chief Executive Officer at Roche Innovation Center Copenhagen A from 2003 to 2008.
He also served as Chairman of Affitech AS, Weifa ASA, The Bioindustry Association, Pharmacy2U Ltd., and ario pharma Ltd. He was Vice Chairman of The European Association for Bioindustries.
He was an Independent Director at Affitech A from 2008 to 2012.
He also worked as a Research Director-United Kingdom at G.D.
Searle LLC.
Dr. McCullagh holds a doctorate degree from the University of Cambridge and an undergraduate degree from the University of Bristol.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Built Cybernetics Plc
 Built Cybernetics Plc Engineering & ConstructionIndustrial Services Provides architectural, interior design and engineering services 10.37% | 2026-03-19 | 41,339,142 ( 10.37% ) | 849 933 $ | 2026-05-30 |
Keith McCullagh active positions
| Companies | Position | Start |
|---|---|---|
Xention Pharma Ltd.
 Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Chairman | - |
Metrion Biosciences Ltd.
 Metrion Biosciences Ltd. BiotechnologyHealth Technology Engages in research and development of ion channel drugs | Chairman | - |
Xention Ltd.
 Xention Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Director/Board Member | 2008-10-28 |
Torpedo Factory Ltd.
 Torpedo Factory Ltd. Information Technology ServicesTechnology Services Operates as a system integration company that provides professional & managed services for stage, audio visual and intelligent environments | Director/Board Member | 2001-12-26 |
Former positions of Keith McCullagh
| Companies | Position | End |
|---|---|---|
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Director/Board Member | 2012-04-26 |
| WEIFA ASA | Chairman | 2010-05-19 |
Affitech AS /Old/
 Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Discovers and develops human therapeutic antibodies | Chairman | 2009-06-15 |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Chief Executive Officer | 2008-06-30 |
| VERNALIS | Chief Executive Officer | 1997-12-31 |
Training of Keith McCullagh
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
38
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
Affitech AS /Old/
Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Discovers and develops human therapeutic antibodies | Commercial Services |
Weifa ASA
 Weifa ASA Pharmaceuticals: MajorHealth Technology Manufactures non-prescription and over-the-counter pharmaceutical products | Health Technology |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector | Commercial Services |
Pharmacy2U Ltd.
 Pharmacy2U Ltd. Drugstore ChainsRetail Trade Operates as an online pharmacy | Retail Trade |
The European Association for Bioindustries | |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Health Technology |
G.D. Searle LLC | |
ario pharma Ltd.
 ario pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of respiratory indications | Health Technology |
Xention Ltd.
Xention Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Health Technology |
Metrion Biosciences Ltd.
Metrion Biosciences Ltd. BiotechnologyHealth Technology Engages in research and development of ion channel drugs | Health Technology |
Torpedo Factory Ltd.
Torpedo Factory Ltd. Information Technology ServicesTechnology Services Operates as a system integration company that provides professional & managed services for stage, audio visual and intelligent environments | Technology Services |
- Stock Market
- Insiders
- Keith McCullagh
Choose MarketScreener 
